asimadoline has been researched along with Eczema, Atopic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abels, C; Ahrens, K; Marsella, R; Soeberdt, M; Wilkes, R | 1 |
| Silverberg, JI; Vakharia, PP | 1 |
2 other study(ies) available for asimadoline and Eczema, Atopic
| Article | Year |
|---|---|
Topical κ-opioid receptor agonist asimadoline improves dermatitis in a canine model of atopic dermatitis.
Topics: Acetamides; Analgesics, Opioid; Animals; Cross-Over Studies; Dermatitis, Atopic; Dog Diseases; Dogs; Double-Blind Method; Prospective Studies; Pruritus; Pyrrolidines; Receptors, Opioid, kappa | 2022 |
New therapies for atopic dermatitis: Additional treatment classes.
Topics: Acetamides; Administration, Topical; Adult; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimicrobial Cationic Peptides; Biological Products; Clinical Trials, Phase II as Topic; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Prognosis; Pyrrolidines; Randomized Controlled Trials as Topic; Treatment Outcome | 2018 |